Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novo Nordisk
Pharma
Novo touts weight loss results in high-dose Wegovy study
In the ongoing quest to expand semaglutide’s clinical pedigree, Novo Nordisk is rolling out new data on a higher-dose injection in obesity.
Fraiser Kansteiner
Jan 17, 2025 9:40am
CMS picks 2nd batch of drugs for IRA price talks
Jan 17, 2025 9:28am
AbbVie maintains top TV ad spend spot with Skyrizi in December
Jan 16, 2025 5:55am
Novo, Lilly launches top Clarivate's 'Drugs to Watch' list
Jan 8, 2025 12:01pm
Wegovy and Zepbound tipped to fuel $20B heart failure boom
Jan 7, 2025 11:12am
Novo asks FDA to restrict compounding of legacy GLP-1 Victoza
Jan 3, 2025 3:25pm
